Navigation Links
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Date:8/3/2009

Wu was vice president of business development at Genelabs Technologies Inc., where he was responsible for all business development and licensing activities, including search, evaluation, contract negotiations for all in- and out-license transactions as well as alliance management and assisting in corporate financing activities. At Genelabs, Wu completed numerous licensing agreements and research collaborations with companies including Novartis, Gilead and Affymetrix.

Prior to Genelabs, Wu participated in the 1997 establishment of Kissei Pharma, the U.S. subsidiary of Kissei Pharmaceuticals Co. of Japan. Wu also was director of business development for Quintiles-BRI, a clinical research organization, after working for 16 years at Syntex Corporation. At Syntex, he held numerous positions with increasing responsibility, beginning as a chemist at the Syntex Research Institute of Pharmaceutical Sciences and culminating as director of R&D Program Planning and Management for the company's Japanese subsidiary.

Wu received his MBA in International Finance from the University of San Francisco, School of Business. He has been a member of the American Association of Pharmaceutical Scientist Planning Committee for Harmonization of Pharmaceutical Science Requirements, the New York Pharma Forum, the Japan Society of Northern California, the Healthcare Study Group (JETRO New York), the Regulatory Affairs Professional Society, and the Licensing Executive Society and Drug Information Association. Wu has been a frequent speaker at conferences including the Bay Bio Panel, Hepatitis C in Search of a Cure, Conducting Clinical Trials in Japan, Pacific Rim Biotech Conference and BIO.

About NovaBay

NovaBay Pharmaceuticals is a mid-stage biopharmaceutical company focused on developing its proprietary and patented Aganocide(R) compounds, which are novel, synthetic anti-infective product candidates that are
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
2. OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
3. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
4. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
5. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
6. Brookstone Pharmaceuticals Appoints New Corporate Position
7. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
8. Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
9. Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
10. Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
11. BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Research and Markets has announced the addition ... Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - ... The global molecular biology enzymes market was ... to grow at a CAGR of 13.74% to reach ... reagents find applications in a large number of fields ...
(Date:8/21/2014)... Aug. 21, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... first in class collagenase-based products marketed as XIAFLEX ... the U.S. and XIAPEX ® in the ... a randomized, double-blind Phase 2a study of CCH ... fibrosclerotic panniculopathy. The results showed that all three ...
(Date:8/21/2014)... , August 21, 2014 ... ) has announced the addition of the  ... to their offering.       (Logo: ... hormone therapy, is a means of replacing ... by the body. This type of therapy ...
(Date:8/21/2014)... , Aug. 21, 2014 Mathematic studies at the ... University , and funded by the Jeffrey Epstein VI ... tumors can be visually identified for elimination. These aggressive cells ... study, which shows a topological map of what to look ... cancer research, for while tumor cells can be extracted from ...
Breaking Biology Technology:Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2
... developer to describe a Web site, youre likely to learn about ... youre likely to learn a lot about pinball. , ,A pinball ... works not the mechanical side of working that involves ASP, ... attracts and retains customers. By thinking of the Internet as a ...
... putting their state into further debt to fund ... California voters approved Proposition 71, which will provide ... decade. , ,The proposition, which was endorsed by ... California Institute for Regenerative Medicine. The institute will ...
... labs at the research park. An investment of $8.5 ... niche-market biotech company to Wisconsin, where it will inhabit brand-new ... ,The company is targeting a type of debilitating genetic disease ... new technique. , , Symbiontics, Inc. , which drew about ...
Cached Biology Technology:My 50 cents: Web sites and pinball machines 2My 50 cents: Web sites and pinball machines 3My 50 cents: Web sites and pinball machines 4Californians: Stem cells important enough to go into debt for 2Wisconsin VCs draw Missouri biotech firm to state 2Wisconsin VCs draw Missouri biotech firm to state 3Wisconsin VCs draw Missouri biotech firm to state 4
(Date:8/21/2014)... finding that has implications for life in other extreme ... solar system, LSU Associate Professor of Biological Sciences Brent ... Foundation, or NSF, this week published a paper confirming ... lies 800 meters (2600 feet) beneath the surface of ... Given that more than 400 subglacial lakes and numerous ...
(Date:8/21/2014)... Saturday to Wednesday, Oct. 18-22, 2014 , ... Harbor Drive, San Diego, CA 92101 , ... other presentations of the latest research in human ... session featuring high-scoring abstracts on rare genetic variants ... cancers, and treatment for sun sensitivity (Saturday, Oct. ...
(Date:8/21/2014)... of researchers at Louisiana Tech University has ... consumer-grade 3D printers and materials to fabricate ... and chemotherapeutic compounds for targeted drug delivery. ... and research faculty from Louisiana Tech,s biomedical ... create filament extruders that can make medical-quality ...
Breaking Biology News(10 mins):800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4American Society of Human Genetics 2014 Annual Meeting 2Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3
... The notion of transplanting adult stem cells to treat or ... toward becoming a reality. In a study published today ... have demonstrated, for the first time, the ability to create ... the eye cells that die and cause loss of sight. ...
... Conservation Society and the State Institute of Animal Health (IAGRO) ... the first health assessments of white-lipped peccaries (medium-sized pig-like animals) ... the impact of Leptospirosis a zoonotic bacteria that affects ... and livestock. The studyconducted between 2003 and 2005 ...
... Exposure to alcohol in the womb doesn,t affect all fetuses ... give birth to a child with physical, behavioral or learning ... another woman who also drinks has a child without these ... by the mother to her son, according to new Northwestern ...
Cached Biology News:Stem cell therapy for age-related macular degeneration -- a step closer to reality 2Monitoring peccaries in Brazil benefits wildlife, local communities and food security 2Monitoring peccaries in Brazil benefits wildlife, local communities and food security 3Why some children are harmed by mother's alcohol, but others aren't 2
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Donor feline serum and plasma...
Request Info...
8 different frozen tissues are mounted on positively charged glass slides...
Biology Products: